Jayman
4 years ago1,000+ Views
Last September the Washington State Liquor Control Board published a 43-page list of proposed guidelines for the sale of recreational marijuana. A few days later, Colorado issued an even longer set of rules, 136 densely packed pages in all. In the realm of legal, commercialized cannabis, a new age is upon us: the age of pungent regulatory skunk. To prove how committed they are to freedom, personal choice, and the pursuit of herbally induced happiness, Washington and Colorado are imposing consumer purchase ceilings, retail sign limits, mandatory packaging requirements, and taxes. What about California? Seventeen years after deciding that marijuana should be at least as permissible as Vicodin, California still has no statewide regulations governing the production and distribution of medical marijuana. Since the U.S. Department of Justice has suggested it will not meddle with pot legalization in states with "strong and effective regulatory and enforcement systems," California is increasingly characterized as a dysfunctional laggard. The onetime medical marijuana trailblazer, concluded a September article in the SF Weekly, is "being left behind, stalled out while other states innovate and attract entrepreneurship." In The Huffington Post that same month, Diane Goldstein, a spokesperson for Law Enforcement Against Prohibition, voiced similar concerns: "In California, it's been the wild, wild west. The laws have been too vague, and when the laws are too vague, it allows people to undermine the law-both the bad apples in the industry and law enforcement." But how accurately does a phrase like "the wild, wild west" describe what has taken place in California? A previously forbidden sector of commerce has evolved into an increasingly professionalized multibillion-dollar industry, complete with a robust retail infrastructure, a lucrative trade in equipment and supplies, trade shows, media outlets, educational institutions, and a surprisingly vast supply of entrepreneurial stoners who seem to get at least as buzzed by marketing, product innovation, and event management as they do by a few puffs of Platinum Skywalker. All without any regulatory hand holding from Sacramento. Recently I visited CW Analytical, a commercial laboratory located in an industrial part of Oakland, across the street from a Mother's Cookies factory. Inside the lab, a technician in a white lab coat hovered intently over a table adorned with an array of small plastic vials partially filled with green liquid. CW Analytical offers voluntary quality assurance services to dispensaries, edibles producers, growers, and consumers who want to analyze the potency and safety of their cannabis. It tests products for microbiological contamination and pesticide exposure, and it offers a range of other services designed to bring transparency, consistency, and reliability to the industry. In 2007 another Oakland-based lab, Steep Hill, pioneered this aspect of the pot trade. Today there are enough labs spread throughout the state to support a trade organization, the Association of Commercial Cannabis Laboratories. According to Robert Martin, who co-founded CW Analytical and heads the association, only around 20 percent of the state's dispensaries currently get their product tested at facilities like his. There have been some questions regarding the accuracy, competence, and impartial status of the labs that have set up shop. Yet the laboratories are another example of the industry's gravitational drift toward order-and another indication of medical marijuana's exceptional status in our current hyper-regulatory climate. We live in an age of pervasive government intervention. The Code of Federal Regulations has added 43,504 pages since California first passed Proposition 215 in 1996. Yet while this bureaucratic bulwark was growing as thick as the Great Wall of China, our nation's largest state, which doubles as the world's eighth-largest economy, was permitting the sale of a substance that had been illegal for 60-plus years. In theory, this wild, wild west should have exploded into chaos, or at least something a little more raucous than a bunch of entrepreneurial Ph.D.s monitoring the fungus levels of freshly cultivated Lemon Kush. Yes, there has been drama over the years: NIMBY complaints, dispensary bans, and, of course, federal raids. But the most visible manifestations of California's medical marijuana industry have been hydro stores in strip malls, advertisements in alternative weeklies, and $12,000 trim machines. While the threat of federal intervention and city-wide regulations have played significant roles in the industry's evolution, capitalism arguably has been its most functional regulator. Take the labs. In California provenance is king: Any heirloom radish without a pedigree is suspect. Consumers want to know where it was grown, who grew it, and the nutritive profile of its mulch. With cannabis, the value of detailed information is even greater than it is for most crops. THC levels can vary greatly depending on growing conditions and techniques. Cannabis is susceptible to mold and fungi, and growers often use pesticides and other potential contaminants. This uncertainty created a business opportunity for entrepreneurs such as Martin. Somewhat surprisingly, consumer demand for more comprehensive information about the latest harvest of Sour Diesel is not yet particularly strong. If it were, then surely more than one in five dispensaries would be regularly testing their products. But the demand for detailed information about heirloom radishes-not to mention Napa Valley cabernets-wasn't always so great either. Over time, organic evangelists and entrepreneurial farmers created that demand. That's the same path the cannabis industry is following today. To make CW Analytical's service attractive to dispensaries, Martin, who previously held executive-level quality assurance and food development positions at Kraft Foods and Dreyer's Ice Cream, is doing everything he can to make it affordable. According to Martin, CW Analytical will run all the tests necessary to determine a sample's potency and safety for $120 a pound, or roughly 25 cents per gram. (In dispensaries, the retail price of a gram generally ranges between $10 and $20.) The labs have a strong incentive to standardize testing methodologies, share best practices, and continue expanding the range of services they offer. Unless they can make themselves crucial to consumers and dispensaries, they won't survive. "In the beginning, all of the edibles were wrapped up in cellophane and sold to you just like that," Martin notes. "There were no allergen statements, no caloric impact statements, nothing but a brownie full of pot. God knows how much pot, though, so you only better eat a little bit. If you ate too much, you could be very uncomfortable. It could send you to the emergency room with an anxiety attack." After decades of working in the food industry, Martin places a strong emphasis on uniformity and clarity. "This started out as a cottage industry, and cottage industries sometimes stick with what works over what's best," he says. "We're trying to get our clients to put the milligrams [of THC] per dosage on their labels. We're trying to get everyone to think in terms of serving sizes, and making their products the same way every time. People need to know that when they buy a certain product, it's going to produce the same effects every time."
0 comments
6
Comment
Share